Pharmacological Treatment of Acute Ischemic Stroke

Critical Care Nursing Quarterly

Volumn 26, Issue 4, 2003, Pages 276-282

  Murphy, Janet ^a  

^a SCRIPPS MERCY HOSPITAL   (United States)

Author keywords

Antiplatelet therapy; Brain attack; Neuroprotectants; Pharmacology; Stroke; Thrombolytics

Indexed keywords

3 (5 CHLORO 2 METHOXYPHENYL) 3 FLUORO 2,3 DIHYDRO 6 TRIFLUOROMETHYL 1H INDOL 2 ONE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACETYLSALICYLIC ACID; ALTEPLASE; ANCROD; APTIGANEL; CALCIUM CHANNEL BLOCKING AGENT; CLOMETHIAZOLE; CLOPIDOGREL; DIAZEPAM; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; GELSOLIN; HEPARIN; SARUPLASE; STREPTOKINASE; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANAPHYLAXIS; BRADYCARDIA; BRAIN EDEMA; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; ECCHYMOSIS; EMBOLISM; EPISTAXIS; FEVER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GENITAL BLEEDING; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART RUPTURE; HEART TAMPONADE; HEMATURIA; HUMAN; HYPOTENSION; LARYNX EDEMA; LUNG EDEMA; MITRAL VALVE REGURGITATION; NAUSEA; NEUTROPENIA; NURSING; PERICARDIAL EFFUSION; PERICARDITIS; PERIPHERAL VASCULAR DISEASE; RASH; RETROPERITONEAL HEMORRHAGE; REVIEW; UNITED STATES; URTICARIA; VEIN THROMBOSIS; VOMITING;

EID: 0142089316     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-200310000-00003     Document Type: Review

References (33)

1. Hickey JV. The Clinical Practice of Neurological and Neurosurgical Nursing. 4th ed. Texas: Lippincott; 1997.
2. Broderick JP, Hacke WH. Treatment of acute ischemic stroke: Part I, Recanalization strategies. Circulation. 2002;106:1563-1569.
3. Oliveira-Filho J, Koroshetz W. Initial treatment of ischemic stroke. Up to Date. 2003. Available at: www.uptodate.com. Retrieved June 9, 2003.
4. Alberts MJ. Diagnosis and treatment of ischemic stroke. Am J Med. 1999;106:211-221.
5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
6. Bravata DM, Kim N, Concato J, et al. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med. 2002;162:1994-2001.
7. Crowther MA, Ginsberg J. Principles of hemostasis and antithrombotic therapy. In: Barnet H, Stein B, Yatsu F, eds. Stroke, Pathophysiology, Diagnosis and Management. 3rd ed. Philadelphia: Churchill Livingstone; 1998:1027-1039.
8. Hinkle JL, Bowman L. Neuroprotection for ischemic stroke. J Neurol Nurs. 2003;35:1-8.
9. Meschia JF, Miller DA, Brott TG. Thrombolytic treatment of acute ischemic stroke. Mayo Clin Proc. 2002;77:542-551.
10. Delmar GS. Alteplase, recombinant. 2001. Available at: http://www.nursespdr.com/members/database/ndrhtml/alteplaserocombinant.htm. Retrieved June 24, 2003.
11. Sherman DG, Atkinson RP, Chippendale T, et al. Intravenous ancrod for treatment of acute ischemic stroke. The STAT Study: a randomized, controlled trial. JAMA. 2000;28:2395-2403.
12. Schellinger PD, Fiebach JB, Mohr A, et al. Thrombolytic therapy for ischemic stroke-a review: Part II, Intra-arterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging. Crit Care Med. 2001;29:1819-1825.
13. Delmar GS. Heparin calcium. 2001. Available at: http://www.nursespdr.com/members/database/ndr html/heparincalcium.html. Retrieved July 7, 2003.
14. Marler JR, Tilley BC, Lu M. Early stroke treatment associated with better outcomes. The NINDS rtPA Stroke Study. Neurology. 200;55:1649-1655.
15. Moonis M, Fisher M. Considering the role of heparin in acute ischemic stroke. Stroke. 2002;33:1927-1933.
16. Caplan LR. Resolved: heparin may be useful in selected patients with brain ischemia. Stroke. 2003;34:231-232.
17. Barker E. Neuroscience Nursing: a Spectrum of Care. 2nd ed. St. Louis: Mosby; 2002.
18. Algra A, DeSchryver EL, van Gijn J, et al. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed origin. Stroke. 2003;34:234-235.
19. Brown M. Brain attack: a new approach to stroke. Clin Med. 2001;1:60-65.
20. Delmar GS. Acetylsalicylic acid. 2001. Available at: http://www.nursespdr.com/members/database/ndr html/acetylsalicylicacid.html. Retrieved July 7, 2003.
21. Grau AJ, Reiners S, Lichy C, et al. Platelet function under aspirin, clopidogrel, and both after ischemic stroke. A case-crossover study. Stroke. 2003;34:849-854.
22. Delmar GS. Ticlopidine. 2001. Available at: http:// www.nursespdr.com/members/database/ndrhtml/ ticlopidinehydrochloride.html. Retrieved July 7, 2003.
23. Weksler BB. Platelet function and antiplatelet agents. In: Barnet H, Stein B, Yatsu F, eds. Stroke, Pathophysiology, Diagnosis and Management. 3rd ed. Philadelphia: Churchill Livingstone; 1998:1041-1059.
24. Delmar GS. Clopidogrel bisulfate. 2001. Available at: http://www.nursespdr.com/members/database/ndr html/clopidogrel.html. Retrieved July 7, 2003.
25. Delmar GS. Dipyridamole. 2001. Available at: http://www.nursespdr.com/members/database/ndrhtml/dipyridamole.html. Retrieved July 7, 2003.
26. Kidwell C, Alger J. New perspectives on diffusion/perfusion MRI in ischemic stroke. UCLA Stroke Cent Neurovasc Program. 2000;1:3-5.
27. Kidwell CS, Saver JL, Mattiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000;47:462-469.
28. Wardlaw JM, Keir SL, Bastin ME, et al. Is diffusion imaging appearance an independent predictor of outcome after ischemic stroke? Neurology. 2002;59:1381-1387.
29. Schellinger PD, Fiebach JB, Hacke W. Image-based decision making in thrombolytic therapy for ischemic stroke. Stroke. 2003;34:575-582.
30. Rother J. Imaging-guided extension of the time window: ready for application in experienced stroke centers? Stroke. 2003;34:582-583.
31. Muir KW. Magnesium in stroke treatment. Postgrad Med J. 2002;78:641-645.
32. Jensen BJ. BMS-204352: a potassium channel opener developed for the treatment of stroke. CNS Drug Rev. 2002;8:353-360.
33. Gladstone DJ, Black SE, Hakim AM. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002;33:2123-2136.